http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016011263-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f04b1dc6b9fcc2d8b159c5ebee364b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-36 |
| filingDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfb168917dd96eb9f2d5faffa787b9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b483f4d57172372d1714f310f4195dc4 |
| publicationDate | 2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016011263-A |
| titleOfInvention | Radiolabeled compound |
| abstract | Provided is a labeled compound that can be detected with high sensitivity by a positron emission tomography (PET) method without using a metabolic inhibitor and can evaluate the dopamine nervous system. A radiolabeled compound represented by formula (1) or a salt thereof. [R 1 is H or an optionally substituted C1-6 linear / branched alkyl group; R 2 and R 3 are each independently H or C1-6 linear / branched alkylcarbonyl. group; R 4 is - 11 CH 3, -C 18 FH 2, or -C 18 FF 2] [Selection figure] None |
| priorityDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.